Transcatheter Aortic Valve Implantation: The Evolving Role of the Radiologist in 2021

Rodrigo Salgado; Haroun El Addouli; Ricardo P J Budde

doi:10.1055/a-1645-1873

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Table of Contents

Rofo 2021; 193(12): 1411-1425
DOI: 10.1055/a-1645-1873

Review

Transcatheter Aortic Valve Implantation: The Evolving Role of the Radiologist in 2021

Transkatheter-Aortenklappenimplantation: Die neue Rolle des Radiologen im Jahr 2021

Authors

Rodrigo Salgado

¹Radiology, UZA, Edegem, Belgium

²Radiology, Holy Heart Hospital Lier, Belgium
Haroun El Addouli

¹Radiology, UZA, Edegem, Belgium
Ricardo P J Budde

³Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands

Abstract

Background Transcatheter aortic valve implantation (TAVI) has gained worldwide acceptance and implementation as an alternative therapeutic option in patients with severe aortic valve stenosis unable to safely undergo surgical aortic valve replacement. This transformative technique places the radiologist in a key position in the pre-procedural assessment of potential candidates for this technique, delivering key anatomical information necessary for patient eligibility and procedural safety. Recent trials also provide encouraging results to potentially extend the indication to patients with safer risk profiles.

Method The review is based on a PubMed literature search using the search terms “transcatheter heart valve”, “TAVI”, “TAVR”, “CT”, “imaging”, “MR” over a period from 2010–2020, combined with personal comments based on the author’s experience.

Results and Conclusion CT plays a prominent role in the pre-procedural workup, delivering as a true 3D imaging modality optimal visualization of the complex anatomy of the aortic root with simultaneous evaluation of the patency of the different access routes. As such, the contribution of CT is key for the determination of patient eligibility and procedural safety. This input is supplementary to the contributions of other imaging modalities and forms an important element in the discussions of the Heart Valve Team. Knowledge of the procedure and its characteristics is necessary in order to provide a comprehensive and complete report. While the role of CT in the pre-procedural evaluation is well established, the contribution of CT and MR and the clinical significance of their findings in the routine follow-up after the intervention are less clear and currently the subject of intense investigation. Important issues remain, including the occurrence and significance of subclinical leaflet thrombosis, prosthetic heart valve endocarditis, and long-term structural valve degeneration.

Key Points:

CT plays a crucial role in evaluating transcatheter heart valve candidates
Evaluation must include the dimensions of the aortic root and access paths
The exact post-procedural role of CT and MRI has not yet been determined.

Citation Format

Salgado R, El Addouli H, Budde RP. Transcatheter Aortic Valve Implantation: The Evolving Role of the Radiologist in 2021. Fortschr Röntgenstr 2021; 193: 1411 – 1425

Zusammenfassung

Hintergrund Die Transkatheter-Aortenklappenimplantation (TAVI) hat sich weltweit als alternative therapeutische Option bei Patienten mit schwerer Aortenklappenstenose durchgesetzt, bei denen ein Aortenklappenersatz durch offene chirurgische Operation zu risikobehaftet wäre. Bei dieser transformativen Technik nimmt der Radiologe eine Schlüsselposition ein, indem er präprozedural potenzielle Kandidaten beurteilt und wichtige anatomische Informationen liefert, die für die Eignung des Patienten und die Sicherheit des Eingriffs notwendig sind. Neuere Studien zeigen auch ermutigende Ergebnisse hinsichtlich einer Ausweitung der Indikation auf Patienten mit sichereren Risikoprofilen.

Methode Die Übersichtsarbeit basiert auf einer PubMed-Literaturrecherche von 2010–2020 mit den Suchbegriffen „transcatheter heart valve“, „TAVI“, „TAVR“, „CT“, „imaging“, „MR“ verbunden mit persönlichen Kommentaren basierend auf der Erfahrung des Verfassers.

Ergebnisse und Schlussfolgerung Die CT spielt eine herausragende Rolle in der präprozeduralen Aufarbeitung und liefert als echte 3D-Bildgebungsmodalität eine optimale Visualisierung der komplexen Anatomie der Aortenwurzel bei gleichzeitiger Beurteilung der Durchgängigkeit der verschiedenen Zugänge. Somit ist der Beitrag der CT entscheidend für die Feststellung der Eignung des Patienten und für die Sicherheit des Eingriffs. Diese Informationen ergänzen die Beiträge der anderen bildgebenden Verfahren und sind ein wichtiges Element der Diskussionen des Herzklappen-Teams. Die Kenntnis des Eingriffs und seiner Charakteristika ist notwendig, um einen umfassenden und vollständigen Bericht zu erstellen. Während die Rolle der CT in der präprozeduralen Evaluation gut etabliert ist, sind der Beitrag von CT und MR und die klinische Bedeutung ihrer Befunde in der routinemäßigen Nachuntersuchung nach dem Eingriff weniger eindeutig und werden derzeit intensiv untersucht. Es bleiben wichtige Fragen offen, einschließlich des Auftretens und der Bedeutung von subklinischen Klappenthrombosen, Endokarditis der Herzklappenprothese und langfristiger struktureller Klappendegeneration.

Kernaussagen:

Die CT spielt eine entscheidende Rolle bei der Beurteilung von Kandidaten für Transkatheter-Herzklappen.
Die Bewertung muss die Dimensionen der Aortenwurzel und der Zugänge umfassen.
Die genaue Rolle von CT und MR nach dem Eingriff ist noch ungeklärt.

Key words

TAVI - aortic valve - aortic valve stenosis - TAVR - CT angiography

Full Text

References

References
1 Cribier A, Eltchaninoff H, Bash A. et al. Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis. Circulation 2002; 106: 3006-3008
2 Mack MJ, Leon MB, Smith CR. et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2477-2484
3 Kapadia SR, Leon MB, Makkar RR. et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2485-2491
4 Salgado RA, Budde RPJ, Leiner T. et al. Transcatheter aortic valve replacement: postoperative CT findings of Sapien and CoreValve transcatheter heart valves. Radiographics Rev Publ Radiological Soc North Am Inc 2014; 34: 1517-36
5 Institut für Transparenz und Qualität im Gesundheitswesen (IQTIG). Undefined n.d.
6 Eggebrecht H, Mehta RH. Transcatheter aortic valve implantation (TAVI) in Germany: more than 100000 procedures and now the standard of care for the elderly. Eurointervention 2019; 14: e1549-e1552
7 Auffret V, Lefevre T, Belle EV. et al. Temporal Trends in Transcatheter Aortic Valve Replacement in France FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol 2017; 70: 42-55
8 Ludman PF. UK TAVI registry. Heart 2019; 105: s2
9 Lutz M, Messika-Zeitoun D, Rudolph TK. et al. Differences in the presentation and management of patients with severe aortic stenosis in different European centres. Open Hear 2020; 7: e001345
10 Landes U, Barsheshet A, Finkelstein A. et al. Temporal trends in transcatheter aortic valve implantation, 2008–2014: patient characteristics, procedural issues, and clinical outcome. Clin Cardiol 2017; 40: 82-88
11 Durko AP, Osnabrugge RL, Mieghem NMV. et al. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur Heart J 2018; 39: 2635-2642
12 Rahhab Z, Faquir NE, Tchetche D. et al. Expanding the indications for transcatheter aortic valve implantation. Nat Rev Cardiol 2020; 17: 75-84
13 Mack MJ, Leon MB, Thourani VH. et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. New Engl J Med 2019; 380: 1695-1705
14 Kolte D, Vlahakes GJ, Palacios IF. et al. Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. J Am Coll Cardiol 2019; 74: 1532-1540
15 Baumgartner H, Falk V, Bax JJ. et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 2017; 38: 2739-2791
16 Francone M, Budde RPJ, Bremerich J. et al. CT and MR imaging prior to transcatheter aortic valve implantation: standardisation of scanning protocols, measurements and reporting – a consensus document by the European Society of Cardiovascular Radiology (ESCR). Eur Radiol 2020; 30: 2627-2650
17 Salgado RA, Leipsic JA, Shivalkar B. et al. Preprocedural CT Evaluation of Transcatheter Aortic Valve Replacement: What the Radiologist Needs to Know. Radiographics 2014; 34: 1491-1514
18 Blanke P, Weir-McCall JR, Achenbach S. et al. Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI) / transcatheter aortic valve replacement (TAVR): An expert consensus document of the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput 2019; 13: 1-20
19 Tomasz P, Mikolaj B, Maciej B. et al. A comparison of aortic root measurements by echocardiography and computed tomography. J Thorac Cardiovasc Surg 2018; 157: 479-486
20 Hamdan A, Guetta V, Konen E. et al. Deformation Dynamics and Mechanical Properties of the Aortic Annulus by 4-Dimensional Computed Tomography Insights Into the Functional Anatomy of the Aortic Valve Complex and Implications for Transcatheter Aortic Valve Therapy. J Am Coll Cardiol 2012; 59: 119-127
21 Michelena HI, Prakash SK, Corte AD. et al. Bicuspid Aortic Valve. Circulation 2014; 129: 2691-2704
22 Roberts WC, Ko JM, Garner WL. et al. Valve Structure and Survival in Octogenarians Having Aortic Valve Replacement for Aortic Stenosis (± Aortic Regurgitation) With Versus Without Coronary Artery Bypass Grafting at a Single US Medical Center (1993 to 2005). Am J Cardiol 2007; 100: 489-495
23 Holmes DR, Mack MJ, Kaul S. et al. 2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2012; 59: 1200-1254
24 Members AF, Vahanian A, Alfieri O. et al. Guidelines on the management of valvular heart disease (version 2012)The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012; 33: 2451-2496
25 Ueshima D, Fovino LN, Brener SJ. et al. Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis. Int J Cardiol 2019; 298: 76-82
26 Jilaihawi H, Chen M, Webb J. et al. A Bicuspid Aortic Valve Imaging Classification for the TAVR Era. Jacc Cardiovasc Imaging 2016; 9: 1145-1158
27 Zhao ZG, Jilaihawi H, Feng Y. et al. Transcatheter aortic valve implantation in bicuspid anatomy. Nat Rev Cardiol 2015; 12: 123-128
28 Mylotte D, Lefevre T, Søndergaard L. et al. Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease. J Am Coll Cardiol 2014; 64: 2330-2339
29 Yoon SH, Lefèvre T, Ahn JM. et al. Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis. J Am Coll Cardiol 2016; 68: 1195-1205
30 Ewe SH, Ng ACT, Schuijf JD. et al. Location and Severity of Aortic Valve Calcium and Implications for Aortic Regurgitation After Transcatheter Aortic Valve Implantation. Am J Cardiol 2011; 108: 1470-1477
31 Pio SM, Bax J, Delgado V. How valvular calcification can affect the outcomes of transcatheter aortic valve implantation. Expert Rev Med Devic 2020; 17: 1-12
32 Fujita B, Kütting M, Seiffert M. et al. Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. European Hear J – Cardiovasc Imaging 2016; 17: 1385-1393
33 Clavel MA, Pibarot P, Messika-Zeitoun D. et al. Impact of Aortic Valve Calcification, as Measured by MDCT, on Survival in Patients With Aortic Stenosis Results of an International Registry Study. J Am Coll Cardiol 2014; 64: 1202-1213
34 Pawade T, Clavel MA, Tribouilloy C. et al. Computed Tomography Aortic Valve Calcium Scoring in Patients With Aortic Stenosis. Circulation: Cardiovascular Imaging 2018; 11: e007146
35 Aggarwal SR, Clavel MA, Messika-Zeitoun D. et al. Sex Differences in Aortic Valve Calcification Measured by Multidetector Computed Tomography in Aortic Stenosis. Circulation Cardiovasc Imaging 2018; 6: 40-47
36 Simard L, Côté N, Dagenais F. et al. Sex-Related Discordance Between Aortic Valve Calcification and Hemodynamic Severity of Aortic Stenosis. Circulation Research 2017; 120: 681-691
37 Nishimura RA, Otto CM, Bonow RO. et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; 70: 252-289
38 Overtchouk P, Modine T. A comparison of alternative access routes for transcatheter aortic valve implantation. Expert Rev Cardiovasc Ther 2018; 16: 749-756
39 Overtchouk P, France CHR, Lille U. et al. Alternate Access for TAVI: Stay Clear of the Chest. Interventional Cardiol Rev 2018; 13: 145
40 Webb JG, Dvir D. Transcatheter Aortic Valve Replacement for Bioprosthetic Aortic Valve Failure. Circulation 2013; 127: 2542-2550
41 Nalluri N, Atti V, Munir AB. et al. Valve in valve transcatheter aortic valve implantation (ViV‐TAVI) versus redo – Surgical aortic valve replacement (redo‐SAVR): A systematic review and meta‐analysis. J Interv Cardiol 2018; 31: 661-671
42 Blanke P, Soon J, Dvir D. et al. Computed tomography assessment for transcatheter aortic valve in valve implantation: The vancouver approach to predict anatomical risk for coronary obstruction and other considerations. J Cardiovasc Comput 2016; 10: 491-499
43 Lederman RJ, Babaliaros VC, Rogers T. et al. Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement From Computed Tomography to BASILICA. Jacc Cardiovasc Interventions 2019; 12: 1197-1216
44 Khan JM, Greenbaum AB, Babaliaros VC. et al. The BASILICA Trial Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction. Jacc Cardiovasc Interventions 2019; 12: 1240-1252
45 Landes U, Sathananthan J, Witberg G. et al. Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses. J Am Coll Cardiol 2021; 77: 1-14
46 Chaturvedi A, Hobbs SK, Ling FS. et al. MRI evaluation prior to Transcatheter Aortic Valve Implantation (TAVI): When to acquire and how to interpret. Insights Imaging 2016; 7: 245-254
47 Pannu HK, Alvarez W, Fishman EK. β-Blockers for Cardiac CT: A Primer for the Radiologist. Am J Roentgenol 2006; 186: S341-S345
48 McParland P, Nicol ED, Harden SP. Cardiac drugs used in cross-sectional cardiac imaging: what the radiologist needs to know. Clin Radiol 2010; 65: 677-684
49 Annoni AD, Andreini D, Pontone G. et al. CT angiography prior to TAVI procedure using third-generation scanner with wide volume coverage: feasibility, renal safety and diagnostic accuracy for coronary tree. Br J Radiology 2018; 91: 20180196
50 Schicchi N, Fogante M, Pirani PE. et al. Third generation dual source CT with ultra-high pitch protocol for TAVI planning and coronary tree assessment: feasibility, image quality and diagnostic performance. Eur J Radiol 2019; 122: 108749
51 Bittner DO, Arnold M, Klinghammer L. et al. Contrast volume reduction using third generation dual source computed tomography for the evaluation of patients prior to transcatheter aortic valve implantation. Eur Radiol 2016; 26: 4497-4504
52 Gohmann RF, Lauten P, Seitz P. et al. Combined Coronary CT-Angiography and TAVI-Planning: A Contrast-Neutral Routine Approach for Ruling-Out Significant Coronary Artery Disease. J Clin Medicine 2020; 9: 1623
53 Puri R, Chamandi C, Rodriguez-Gabella T. et al. Future of transcatheter aortic valve implantation – evolving clinical indications. Nat Rev Cardiol 2018; 15: 57-65
54 Taramasso M, Pozzoli A, Latib A. et al. New devices for TAVI: technologies and initial clinical experiences. Nat Rev Cardiol 2014; 11: 157-167
55 Wilson R, McNabney C, Weir-McCall JR. et al. Transcatheter Aortic and Mitral Valve Replacements. Radiologic Clinics of North America 2018; 57: 165-178
56 Lell MM, Kachelrieß M. Recent and Upcoming Technological Developments in Computed Tomography: High Speed, Low Dose, Deep Learning, Multienergy. Invest Radiol 2020; 55: 8-19
57 Franzesi CRT, Ippolito D, Riva L. et al. Diagnostic value of iterative reconstruction algorithm in low kV CT angiography (CTA) with low contrast medium volume for transcatheter aortic valve implantation (TAVI) planning: image quality and radiation dose exposure. Br J Radiology 2018; 91: 20170802
58 Mayr A, Klug G, Reinstadler SJ. et al. Is MRI equivalent to CT in the guidance of TAVR? A pilot study. Eur Radiol 2018; 28: 4625-4634
59 Ruile P, Blanke P, Krauss T. et al. Pre-procedural assessment of aortic annulus dimensions for transcatheter aortic valve replacement: comparison of a non-contrast 3D MRA protocol with contrast-enhanced cardiac dual-source CT angiography. European Hear J – Cardiovasc Imaging 2016; 17: 458-466
60 Lindman BR, Clavel MA, Mathieu P. et al. Calcific aortic stenosis. Nat Rev Dis Primers 2016; 2: nrdp20166
61 Barone-Rochette G, Piérard S, de Ravenstein CDM. et al. Prognostic Significance of LGE by CMR in Aortic Stenosis Patients Undergoing Valve Replacement. J Am Coll Cardiol 2014; 64: 144-154
62 Podlesnikar T, Delgado V, Bax JJ. Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease. Int J Cardiovasc Imaging 2018; 34: 97-112
63 Calin A, Mateescu AD, Popescu AC. et al. Role of advanced left ventricular imaging in adults with aortic stenosis. Heart 2020; 106: 962-969
64 Backhaus SJ, Lange T, Beuthner BE. et al. Real-time cardiovascular magnetic resonance T1 and extracellular volume fraction mapping for tissue characterisation in aortic stenosis. J Cardiov Magn Reson 2020; 22: 46
65 Puls M, Beuthner BE, Topci R. et al. Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis. Eur Heart J 2020; 41: 1903-1914
66 Leon MB, Smith CR, Mack M. et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. New Engl J Medicine 2010; 363: 1597-1607
67 Tamburino C, Capodanno D, Ramondo A. et al. Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis. Circulation 2011; 123: 299-308
68 Kodali SK, Williams MR, Smith CR. et al. Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement. New Engl J Medicine 2012; 366: 1686-1695
69 Salaun E, Jacquier A, Theron A. et al. Value of CMR in quantification of paravalvular aortic regurgitation after TAVI. European Hear J – Cardiovasc Imaging 2016; 17: 41-50
70 Crouch G, Tully PJ, Bennetts J. et al. Quantitative assessment of paravalvular regurgitation following transcatheter aortic valve replacement. J Cardiov Magn Reson 2015; 17: 32
71 Ribeiro HB, Ven FL, Larose É. et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation. Heart 2014; 100: 1924
72 Abdelghani M, Soliman OII, Schultz C. et al. Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal. Eur Heart J 2016; 37: 2627-2644
73 Ribeiro HB, Orwat S, Hayek SS. et al. Cardiovascular Magnetic Resonance to Evaluate Aortic Regurgitation After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2016; 68: 577-585
74 Archer GT, Elhawaz A, Barker N. et al. Validation of four-dimensional flow cardiovascular magnetic resonance for aortic stenosis assessment. Sci Rep-Uk 2020; 10: 10569
75 Trauzeddel RF, Löbe U, Barker AJ. et al. Blood flow characteristics in the ascending aorta after TAVI compared to surgical aortic valve replacement. Int J Cardiovasc Imaging 2016; 32: 461-467
76 Habib G, Lancellotti P, Antunes MJ. et al. 2015 ESC Guidelines for the management of infective endocarditisThe Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36: 3075-3128
77 Habib G, Erba PA, Iung B. et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J 2019; 40: 3222-3232
78 Sohail MR, Martin KR, Wilson WR. et al. Medical Versus Surgical Management of Staphylococcus aureus Prosthetic Valve Endocarditis. Am J Medicine 2006; 119: 147-154
79 Habib G, Derumeaux G, Avierinos JF. et al. Value and limitations of the duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 1999; 33: 2023-2029
80 Habets J, Tanis W, Reitsma JB. et al. Are novel non-invasive imaging techniques needed in patients with suspected prosthetic heart valve endocarditis? A systematic review and meta-analysis. Eur Radiol 2015; 25: 2125-2133
81 Swart LE, Gomes A, Scholtens AM. et al Improving the Diagnostic Performance of 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Prosthetic Heart Valve Endocarditis. Circulation 2018; 138: CIRCULATIONAHA.118.035032
82 Swart LE, Scholtens AM, Tanis W. et al. 18F-fluorodeoxyglucose positron emission/computed tomography and computed tomography angiography in prosthetic heart valve endocarditis: from guidelines to clinical practice. Eur Heart J 2018; 39: 3739-3749
83 Makkar RR, Fontana G, Jilaihawi H. et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. New Engl J Medicine 2015; 373: 2015-2024
84 Chakravarty T, Søndergaard L, Friedman J. et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. The Lancet 2017; 389: 2383-2392
85 Dalén M, Sartipy U, Cederlund K. et al. Hypo‐Attenuated Leaflet Thickening and Reduced Leaflet Motion in Sutureless Bioprosthetic Aortic Valves. Journal of the American Heart Association 2017; 6: e005251
86 Kalra A, Raza S, Puri R. et al. Subclinical Leaflet Thrombosis and Clinical Outcomes after TAVR: A Systematic Review and Meta-Analysis. Structural Heart 2018; 2: 223-228
87 Woldendorp K, Doyle MP, Black D. et al. Subclinical valve thrombosis in transcatheter aortic valve implantation: A systematic review and meta-analysis. J Thorac Cardiovasc Surg 2020; 162: 1491-1499
88 Sondergaard L, Backer O, Kofoed KF. et al. Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves. European Heart Journal 2017; 38: 2201-2207
89 Nijenhuis VJ, Brouwer J, Søndergaard L. et al. Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation. Heart 2019; 105: 742
90 Nijenhuis VJ, Brouwer J, Delewi R. et al. Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. New Engl J Med 2020; 382: 1696-1707
91 Jilaihawi H, Asch FM, Manasse E. et al. Systematic CT Methodology for the Evaluation of Subclinical Leaflet Thrombosis. JACC. Cardiovascular Imaging 2017; 10: 461-470
92 Capodanno D, Petronio AS, Prendergast B. et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardio-Thorac 2017; 52: 408-417
93 Didier R, Eltchaninoff H, Donzeau-Gouge P. et al. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients. Circulation 2018; 138: 2597-2607
94 Durand E, Sokoloff A, Urena-Alcazar M. et al. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition. Circulation Cardiovasc Interventions 2019; 12: e007597
95 Sellers SL, Turner CT, Sathananthan J. et al. Transcatheter Aortic Heart Valves Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration. JACC: Cardiovascular Imaging 2018; 12: 135-145
96 Cartlidge TRG, Doris MK, Sellers SL. et al. Detection and Prediction of Bioprosthetic Aortic Valve Degeneration. J Am Coll Cardiol 2019; 73: 1107-1119